Form 4: Pfizer CEO Albert Bourla Acquires Phantom Stock Units Through Savings Plan

Pfizer's CEO, Albert Bourla, acquired 21 phantom stock units through the company's Supplemental Savings Plan, as reported in a recent SEC filing.

Summary

• Albert Bourla, the Chairman and CEO of Pfizer, acquired 21 phantom stock units on November 15, 2024.
• These units were obtained through the Pfizer Supplemental Savings Plan.
• Each unit represents one phantom share of Pfizer common stock.
• The units will be settled in cash after Mr. Bourla's separation from service.
• Mr. Bourla has the option to transfer these units into an alternative investment account at any time.
• Following this transaction, Mr. Bourla directly owns 691,116 shares of Pfizer common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally. The acquisition of phantom stock units is a standard practice and does not indicate any significant positive or negative sentiment.

Positives

• The acquisition of phantom stock units through the savings plan is a common practice for executive compensation.
• The ability to transfer the units to an alternative investment account provides flexibility for Mr. Bourla.

Future Outlook

The phantom stock units will be settled in cash upon Mr. Bourla's separation from service, or can be transferred to an alternative investment account at any time.

Industry Context

This type of transaction is typical for executive compensation packages in publicly traded companies, aligning executive interests with shareholder value.

Comparison to Industry Standards

• Many large pharmaceutical companies use similar stock-based compensation plans for their executives.
• These plans often include phantom stock units, restricted stock, and stock options.
• The vesting and settlement terms are generally aligned with industry best practices to retain key talent.
• Companies like Johnson & Johnson and Merck also utilize similar compensation structures for their top executives.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it is part of the standard executive compensation package.
• The acquisition of phantom stock units aligns the CEO's interests with the long-term performance of the company.

Key Dates

Keywords

Pfizer, Albert Bourla, phantom stock units, SEC Form 4, executive compensation, Supplemental Savings Plan, insider trading